Results 151 to 160 of about 10,605 (184)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2006
A 16-year-old boy with a history of severe persistent asthma despite treatment with inhaled corticosteroids presents for evaluation. Treatment with omalizumab, a monoclonal anti-IgE antibody, is recommended. This agent has been found to reduce the frequency of exacerbations of asthma in clinical trials.
Robert C, Strunk, Gordon R, Bloomberg
openaire +2 more sources
A 16-year-old boy with a history of severe persistent asthma despite treatment with inhaled corticosteroids presents for evaluation. Treatment with omalizumab, a monoclonal anti-IgE antibody, is recommended. This agent has been found to reduce the frequency of exacerbations of asthma in clinical trials.
Robert C, Strunk, Gordon R, Bloomberg
openaire +2 more sources